Hypoxic hepatitis: A challenging diagnosis

Hepatology International

Volumn 6, Issue 4, 2012, Pages 663-669

  Trilok, Goolab ^a   Qing, Yang Chang ^a   Li Jun, Xu ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Hypoxic hepatitis; Ischemia; Reperfusion injury

Indexed keywords

CALCIUM ION; CALPAIN; CHLORPROMAZINE; DOBUTAMINE; GALACTOSE; HEME OXYGENASE 1; NANOPARTICLE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RESVERATROL; SMALL INTERFERING RNA;

ADVERSE OUTCOME; CALCIUM TRANSPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DIABETIC KETOACIDOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; ECHOGRAPHY; HEPATITIS; HUMAN; HYPOXIC HEPATITIS; LABORATORY TEST; LIVER FIBROSIS; LIVER FUNCTION; LIVER ISCHEMIA; LIVER PROTECTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 84874110091     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-011-9336-1     Document Type: Review

References (79)

1. Bynum T, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci 1979;24:129-135
2. Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: Underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009;35:1397-1405
3. Birrer R, Takuda Y, Takara T. Hypoxic hepatopathy: Pathophysiology and prognosis. Intern Med 2007;46:1063-1070
4. Whitehead N, Hawkes ND, Hainsworth I, et al. A prospective study of the causes of notably raised aminotransferase of liver origin. Gut 1999;45:129-133
5. Johnson R, O'Connor C, Kerr RM. Extreme serum elevations of aspartate aminotransferase. Am J Gastroenterol 1995;90:1244-1245.
6. Henrion J, Schapira M, Luwart R, et al. Hypoxic hepatitis: Clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003;82:392-406
7. Henrion J, Descamps O, Luwaert R, et al. Hypoxic hepatitis in patients with cardiac failure: Incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 1994;21:696-703
8. Pauwels A, Levy VG. Ischemic hepatitis in cirrhosis: Not so rare, not always lethal. J Clin Gastroenterol 1993;17:88-89
9. Kamiyama T, Miyakawa H, Tajiri K, Marumo F, Sato C. Ischemic hepatitis in cirrhosis: Clinical features and prognostic implications. J Clin Gastroenterol 1996;22:126-130
10. Rashed KA, McNabb WR, Lewis RR. Ischaemic hepatitis in the elderly. Gerontology 2002;48:245-249
11. Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis: Clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998;26:183-186
12. Raman JS, Kochi K, Morimatsu H, Buxton B, Bellomo R. Severe ischemic early liver injury after cardiac surgery. Ann Thorac Surg 2002;74:1601-1606
13. Cohen JA, Kaplan MM. Left-sided heart failure presenting as hepatitis. Gastroenterology 1978;74:583-587
14. Henrion J, Schapira M, Heller FR. Ischemic hepatitis: The need for precise criteria. J Clin Gastroenterol 1996;23:305
15. Ucgun A, Ozakyol M, Metintas H, et al. Relationship between hypoxic hepatitis and cor pulmonale in patients treated in the respiratory ICU. Int J Clin Pract 2005;59(11):1295-1300
16. Blich M, Shinon E, Manshano R, Edoute Y. Ischemic hepatitis induced by severe anemia. IMAJ 2003;5:208-209
17. Szypowska A, et al. Acute hypoxic hepatopathy: Diabetic ketoacidosis complication in an infant newly diagnosed with type 1 diabetes mellitus. Pediatr Endocrinol Diabetes Metab 2008;14: 249-251
18. de Kerguennec CD, Bernuau J, et al. Acute hypoxic hepatitis ('liver shock'): Still a frequently overlooked cardiological diagnosis. Eur J Heart Fail 2004;6:561-565
19. Henrion J, Minette P, Colin L, Schapira M, Delannoy A, Heller FR. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: A case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 1999;29:427-433
20. Leslie BR, Head LH, Scharfenberg JC. Ischemic hepatitis from aortic dissection. Ann Intern Med 1989;110:495
21. Vivarelli M, Cucchetti A, La Barba G, et al. Ischemic arterial complications after liver transplantation in the adult: Multivariate analysis of risk factors. Arch Surg 2004;139:1069-1074
22. Shin H, Yozu R, Sumida T, Kawada S. Acute ischemic hepatic failure resulting from intraaortic balloon pump malposition. Eur J Cardiothorac Surg 2000;17:492-494
23. von Glinski KS, Krettek C, Blauth M, Oldhafer K-J. Hepatic ischemia as a complication after correction of post-traumatic gibbus at the thoracolumbar junction. Spine 2000;25:1040-1044
24. Webster GJM, Kurtovic J, Lowe SA, Riordan SM. Hepatic ischemia associated with coarctation of the aorta in pregnancy: Key issues in differential diagnosis. Obstet Gynecol 2004;104: 1151-1154
25. Shibayama Y, Hashimoto K, Nakata K. Hepatic haemodynamics and microvascular architecture after portal venular embolization in the rat. J Hepatol 1992;14:94-98
26. Thurman RG, Ji S, Lemasters JJ. Alcohol-induced liver injury: The role of oxygen. Recent Dev Alcohol 1984;2:103-117
27. French SW, Benson NC, Sun PS. Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology 1984;4:912-917
28. Dahn MS, Wilson RF, Lange P, Stone A, Jacobs LA. Hepatic parenchymal oxygen tension following injury and sepsis. Arch Surg 1990;125:441-443
29. Wiedersberg H, Pawlowski P. Anemic necrosis of the liver after umbilical vein catheterization. Helv Paediatr Acta 1979;34:53-62
30. Menon KVN, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004;350:578-85
31. Han D-W. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 2002;8:961-965
32. Asaka S, Shibayama Y, Nakata K. Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: Microscopic observation in vivo. Liver 1996;16:183-187
33. Ring A, Stremmel W. The hepatic microvascular responses to sepsis. Semin Thromb Hemost 2000;26:589-594
34. Shibayama Y, Urano T, Asaka S, Hashimoto K, Nakata K. Pathogenesis of centrilobular necrosis following congestion of the liver. J Gastroenterol Hepatol 1993;8:530-534
35. Shibayama Y. The role of hepatic venous congestion and endotoxaemia in the production of fulminant hepatic failure secondary to congestive heart failure. J Pathol 1987;151:133-138
36. Henrion J, Colin L, Schapira M, Heller FR. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997;24:245-249
37. Mathurin P, Durand F, Ganne N, et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995;109:1682-1684
38. Omata M, Johnson CS, Tong M, Tatter D. Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci 1986;31: 247-256
39. Charlotte F, Bachir D, Nenert M, et al. Vascular lesions of the liver in sickle cell disease: A clinicopathological study in 26 living patients. Arch Pathol Lab Med 1995;119:46-52
40. Teixeira AL, Viana MB, Roquete ML, Toppa NH. Sickle cell disease: A clinical and histopathologic study of the liver in living children. J Pediatr Hematol Oncol 2002;24:125-129
41. Mills LR, Mwakyusa D, Milner PF. Histopathologic features of liver biopsy specimens in sickle cell disease. Arch Pathol Lab Med 1988;112:290-294
42. Bauer TW, Moore GW, Hutchins GM. The liver in sickle cell disease: A clinicopathologic study of 70 patients. Am J Med 1980;69:833-837
43. Banerjee S, Owen C, Chopra S. Sickle cell hepatopathy. Hepatology 2001;33:1021-1028
44. Sheehy TW. Sickle cell hepatopathy. South Med J 1977;70: 533-538
45. Saltzman JR, Johnston DE. Sickle cell crisis and cocaine hepatotoxicity. Am J Gastroenterol 1992;87:1661-1664
46. Friedman LS. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Gastroenterol Hepatol 2004;1:98-105
47. Cesur S, et al. Acute hepatic failure in a case of acute lymphoblastic leukemia. Tur J Med Sci 2004;34:275-279
48. Verschuur A. Acute myelomonocytic leukemia. Orphanet Encyclopedia. May 2004
49. Kumar V, Abbas AK, Fausto N. Cellular adaptations, cell injury, and cell death. In Kumar V, Abbas AK, Fausto N, editors. Robbins and Cotrans Pathologic Basis of Disease. 7th ed. PA: Elsevier; 2005. 3-46.
50. Massip-Salcedo M, Roselló-Catafau J, Prieto J, et al. The response of the hepatocyte to ischemia. Liver Int 2007;27: 6-16
51. Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 1991;79:115
52. Cursio R, Guggenheim J, Ricci J, et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischaemia by inhibition of liver apoptosis. FASEB J 1999;13:253-261
53. Yadav SS, Howell DN, Steeber DA, et al. P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999;29: 1494
54. Lentsch AB, Kato A, Yoshidome H. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000;32(2):169-173
55. Kohli V, Madden JF, Bentley RC, Clavien PA. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 1999;116:168-178
56. Camargo CA Jr, Madden JF, Gao W. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997;26:1513
57. Wang Y, Mathews WR, Guido DM, et al. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 1995;4(4):282-8
58. Fuhrmann V, Jager B, Zubkova A, et al. Hypoxic hepatitis: Epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010;122:129-139
59. Stravitz R, Kramer A, Davern T, et al. Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007;35:2498-2508
60. De Jonghe B, Cheval C, Misset B, et al. Relationship between blood lactate and early hepatic dysfunction in acute circulatory failure. J Crit Care 1999;14:7-11
61. Kahn JA, Haker KM, Petrovic LM, Arnaout WS, Koobatian G, Fong TL. Radiographic findings of ischemic hepatitis in a cirrhotic patient. J Comput Assist Tomogr 2000;24:887-889
62. Motoyama S, Minamiya Y, Saito S, et al. Hydrogen peroxide derived from hepatocytes induces sinusoidal endothelial cell apoptosis in perfused hypoxic rat liver. Gastroenterology. 1998;114:153-163
63. Schenk P, Schoniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-1052
64. Fuhrmann V, Madl C, Mueller C, et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006;131:67-69
65. Gitlin N, Serio K. Ischemic hepatitis: Widening horizons. Am J Gastroenterol 1992;87:831-836
66. Fuhrmann V, Drolz A, Kneidinger N, et al. Hyperammonemia in patients with hypoxic hepatitis. Gut 2009;58(Suppl2):P0450
67. Mitzner S, Stange J, Klammt S, et al. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001; 12:S75-S82
68. Stefoni S, Coli L, Bolondi L, et al. Molecular adsorbent recirculating system (MARS) application in liver failure: Clinical and hemodepurative results in 22 patients. Int J Artif Organs 2006; 29:207-218
69. Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices in systemic haemodynamics and vasoactive agents in patients with acute-on-chronic liver failure. Crit Care 2006;10:R108
70. Schmidt L, Wang LP, Hansen BA, et al. Systemic hemodynamic effects of treatment with the molecular adsorbent recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 2003;9:290-297
71. Sen S, Loock J, Peszynski P, et al. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005;43:142-148
72. Hetz H, Faybik P, Berlakovich G, et al. Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation. Liver Transpl 2006;12:1357-1364
73. Kume M, Yamamoto Y, Yamagami K, et al. Pharmacological hepatic preconditioning: Involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin. Br J Surg 2000;87:1168-1175
74. Gedik E, Girgin S, Ozturk H, Obay BD, Ozturk H, Buyukbayram H. Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J Gastroenterol 2008;14(46):7101-7106
75. Duchen MR. Mitochondria and calcium: From cell signalling to cell death. J Physiol 2000;529(Pt 1):57-68
76. Gerbes AL, Vollmar AM, Kiemer AK, Bilzer M. The guanylate cyclase-coupled natriuretic peptide receptor: A new target for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology 1998;28:1309-1317
77. Raddatz A, Kubulus D, Winning J, et al. Dobutamine improves liver function after hemorrhagic shock through induction of heme oxygenase-1. Am J Respir Crit Care Med 2006;174(2):198-207
78. Bilbao G, Contreras JL, et al. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic bcl-2 gene. Ann Surg 1999;230(2):185
79. Jiang N, Zhang X, Zheng X, et al. Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury. Am J Transplant 2011;11(9):1835-1844